Allergic Conjunctivitis

Showing 1 - 25 of 121

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Nov 29, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • HPMC-HA eyedrops
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)

Completed
  • Allergic Conjunctivitis
  • PRT-2761 0.5%
  • +4 more
  • Andover, Massachusetts
    Andover Eye Associates
Oct 13, 2022

Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)

Completed
  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Eye Drops, Solution in Single-Dose Container
  • Vienna, Austria
    Vienna Challenge Chamber
Aug 24, 2022

Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)

Recruiting
  • Allergic Conjunctivitis
  • olopatadine hydrochloride ophthalmic solution 0.7%)
  • +3 more
  • Andover, Massachusetts
    Andover Eye Associates
Jul 18, 2022

Allergic Asthma, Allergy to Cats, Allergy to Dust Mites Trial in Iowa City, Boston (Segmental allergen challenge)

Recruiting
  • Allergic Asthma
  • +4 more
  • Segmental allergen challenge
  • Iowa City, Iowa
  • +1 more
May 26, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
May 5, 2022

Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)

Completed
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Vanda Investigational Site
Apr 26, 2022

Tyrosine Allergoid Paediatric and Adult Study

Recruiting
  • Allergic Rhinitis Due to Pollen
  • +2 more
  • MATA trees or MATA grass
  • Augsburg, Germany
    Universitätsklinikum Augsburg
Jan 10, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jan 3, 2022

Allergic Conjunctivitis Trial in United States (Bilastine Ophthalmic Solution 0.6%, Ketotifen Ophthalmic Solution 0.025%

Completed
  • Allergic Conjunctivitis
  • Bilastine Ophthalmic Solution 0.6%
  • +2 more
  • Phoenix, Arizona
  • +5 more
Nov 16, 2021

Allergic Conjunctivitis Trial in Andover (Bilastine 0.2%, Bilastine 0.4%, Bilastine 0.6%)

Completed
  • Allergic Conjunctivitis
  • Bilastine 0.2%
  • +3 more
  • Andover, Massachusetts
    Ora Clinical Research Center
Oct 28, 2021

Allergic Conjunctivitis Trial in Spain (Bilastine, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • A Coruña, Spain
  • +15 more
Oct 13, 2021

Allergic Conjunctivitis Trial in United States (Dexamethasone, 0.4mg, Placebo plug with no drug)

Completed
  • Allergic Conjunctivitis
  • Dexamethasone, 0.4mg
  • Placebo plug with no drug
  • Colorado Springs, Colorado
  • +5 more
Sep 9, 2021

Allergic Conjunctivitis Trial in Andover, Memphis (ST266, Saline (0.9% NaCl))

Completed
  • Allergic Conjunctivitis
  • ST266
  • Saline (0.9% NaCl)
  • Andover, Massachusetts
  • +1 more
Sep 14, 2021

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse

Recruiting
  • Dry Eye Syndrome
  • +3 more
  • Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry
  • Montreal, Quebec, Canada
  • +1 more
Jul 29, 2021

Allergic Conjunctivitis Trial in Andover (Lifitegrast, Placebo)

Completed
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Ora
Jun 2, 2021

Allergic Conjunctivitis Trial in Memphis (EM-100, Zaditor®, Vehicle)

Completed
  • Allergic Conjunctivitis
  • Memphis, Tennessee
    Total Eye Care, PA
Apr 23, 2021

Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis, Allergic Rhinoconjunctivitis Trial in Austin, Grapevine, San

Completed
  • Allergic Rhinitis Due to Tree Pollen
  • +2 more
  • Intra-lymphatic allergenic extract
  • Intra-lymphatic placebo
  • Austin, Texas
  • +2 more
Mar 29, 2021

Allergic Rhinitis, Allergic Conjunctivitis Trial in Andover (Fluticasone Propionate Nasal Spray, Saline Nasal Spray)

Completed
  • Allergic Rhinitis
  • Allergic Conjunctivitis
  • Fluticasone Propionate Nasal Spray
  • Saline Nasal Spray
  • Andover, Massachusetts
    Ora, Inc.
Mar 24, 2021